Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 233 posts found.

teva_copy

Teva to cut over 300 production jobs in Israel

July 24, 2017
Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, generics, healthcare, pharma, pharmaceutical

Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 21, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …

News
teva_copy

Teva asthma treatment scores NICE approval

July 20, 2017
Sales and Marketing Teva, asthma, biotech, cinqaero, drugs, healthcare, pharma, pharmaceuticals

NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an …

News
pascal_soriot

AstraZeneca’s Soriot Teva switch scotched

July 17, 2017
Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical

The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …

News
pascal_soriot

AstraZeneca’s CEO set for shock switch to Teva

July 13, 2017
Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical

It is no secret that Teva has been on the lookout for a new CEO and they had already been …

News
teva_copy

Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm

July 12, 2017
Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals

Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …

News
fdaoutsideweb

FDA approves first generic versions of Lilly’s ADHD drug

May 31, 2017
Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva

The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …

News
sicorbio

500 staff face the axe as Teva cans Hungary plant

May 18, 2017
Manufacturing and Production Teva

Israeli pharmaceutical firm Teva has announced that it plans to cease operations at a manufacturing plant in Gödöllő in Budapest, …

News
teva_copy

Teva and Active Biotech hit by Phase 3 drug failure

May 8, 2017
Research and Development, Sales and Marketing Active Biotech, Teva

Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …

News
eyal-desheh

Teva has another high profile role to fill

April 27, 2017
Sales and Marketing Eyal Desheh, Teva, Teva Pharmaceuticals

Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh is set to leave his …

News
teva_canada

Teva launches competitors to GSK’s Advair inhaler

April 21, 2017
Medical Communications, Sales and Marketing Advair, AirDuo, GSK, Teva, asthma

GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the …

News
teva_copy

Teva’s Huntington’s treatment becomes first FDA-approved deuterated drug

April 4, 2017
Manufacturing and Production, Sales and Marketing Austedo, FDA, Teva

Israel’s Teva Pharmaceuticals has announced that the FDA has given its approval for Austedo (deutetrabenazine) in the treatment of chorea …

News

Pfizer plant receives FDA warning letter for contamination of medicine

March 1, 2017
Manufacturing and Production Copaxone, Mylan, Pfizer, Teva, generics

The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …

News
erez_vigodman

Teva’s Vigodman becomes third CEO to leave in 5 years

February 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …

Appointment
debrecenhungary

More troubles for Teva as Israeli authorities open bribery investigation

February 8, 2017
Research and Development, Sales and Marketing Teva, bribery

Teva continues to struggle this week; after being hit with the bombshell that CEO Erez Vigodman, its third chief executive …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023